Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Depression 4 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Anxiety Disorders 2 Urologic Diseases 1 Treatment Adherence and Compliance 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sarcoma 1 Radiation Fibrosis Syndrome 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Hemorrhage 1 Peripheral Lung Tumor 1 Patient Acceptance of Health Care 1 Obesity 1 Neoplasm Metastasis 1

Interventions

Imipramine 2 Fluorouracil 2 Aminolevulinic Acid 2 green tea extract polyphenone E 1 Tomography, Optical Coherence 1 Therapeutics 1 Powders 1 Ointments 1 Control Groups 1 Aluminum Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Keratosis, Actinic × Therapeutics × Clear all

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡